Chronic myeloid leukemia (CML) is a type of cancer that affects the bone marrow and blood cells. The survival outcomes of this disease are influenced by various factors, such as the phase of the disease, the age and overall health of the individual, and treatment effectiveness. In the United States, individuals with CML have a five-year survival rate of 70.4%[1]. This means that approximately seven out of every ten people diagnosed with CML will survive for at least five years after their diagnosis. However, it is important to note that this survival rate can vary depending on several factors.
The National Cancer Institute reports that almost 65.1% of those diagnosed with CML survive for at least five years after their diagnosis[2]. This indicates that there have been significant advancements in medical treatments for CML over the years. A comprehensive study on CML patients treated with imatinib revealed that about 90% survived five years after commencing therapy[3]. Imatinib is a medication used to treat CML by targeting specific proteins in cancer cells.
Currently, the ten-year survival rate for the most prevalent type of CML is approximately 85%[4]. This means that patients can anticipate lifespans nearly equivalent to healthy adults if they receive proper treatment and care. It is essential to monitor and manage any side effects associated with treatment to ensure optimal outcomes.
It is worth noting that around 90 out of every hundred people (approximately 90%) will survive leukaemia for more than five years following their diagnosis[5]. While this may provide some comfort, it is crucial to seek medical attention promptly if any symptoms or changes in health occur.
In conclusion, while chronic myeloid leukemia can be a challenging condition to manage, there are effective treatments available that can significantly improve patient outcomes. It is essential to work closely with healthcare professionals and adhere to recommended treatments to ensure optimal results. With proper care and management, individuals living with CML can live long and fulfilling lives.
Citations:
[1] https://www.myleukemiateam.com/resources/chronic-myeloid-leukemia-survival-rates-and-outlook
[2] https://www.healthline.com/health/chronic-myeloid-leukemia/outlook-life-expectancy
[4] https://www.lls.org/research/chronic-myeloid-leukemia-cml
[5] https://www.cancerresearchuk.org/about-cancer/chronic-myeloid-leukaemia-cml/survival
